Syros Pharmaceuticals Stock Market Value
| SYRS Stock | USD 0.0002 0.0001 33.33% |
| Symbol | Syros |
Syros Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Syros Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Syros Pharmaceuticals.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Syros Pharmaceuticals on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Syros Pharmaceuticals or generate 0.0% return on investment in Syros Pharmaceuticals over 90 days. Syros Pharmaceuticals is related to or competes with Pasithea Therapeutics, Coeptis Therapeutics, Revelation Biosciences, Dermata Therapeutics, and Purple Biotech. Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monoge... More
Syros Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Syros Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Syros Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Syros Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Syros Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Syros Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Syros Pharmaceuticals historical prices to predict the future Syros Pharmaceuticals' volatility.Syros Pharmaceuticals Backtested Returns
Syros Pharmaceuticals is out of control given 3 months investment horizon. Syros Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.21, which indicates the firm had a 0.21 % return per unit of risk over the last 3 months. We were able to interpolate data for six different technical indicators, which can help you to evaluate if expected returns of 17.91% are justified by taking the suggested risk. Use Syros Pharmaceuticals Relative Strength Index of 47.78, price action indicator of (0.00005), and Rate Of Daily Change of 0.67 to evaluate company specific risk that cannot be diversified away. Syros Pharmaceuticals holds a performance score of 16 on a scale of zero to a hundred. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Syros Pharmaceuticals are completely uncorrelated. Use Syros Pharmaceuticals rate of daily change , to analyze future returns on Syros Pharmaceuticals.
Auto-correlation | 0.08 |
Virtually no predictability
Syros Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Syros Pharmaceuticals time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Syros Pharmaceuticals price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Syros Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Syros Pink Sheet Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.